ABVX
Abivax SA
NASDAQ · Healthcare · Biotechnology · FR
$87.49
−0.73%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-110.6%
Return on equity
-87.6%
Return on assets
-77.2%
Return on invested capital
0.00x
Asset turnover
-$138.3M
Cash from operations
$5.28
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026